Saira Sundus, MD
Endocrinology, Diabetes & Metabolism · Flint, MINPI 1265953988
Payments from drug & device makers
Across 530 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Amgen$1K
- Corcept Therapeutics$936
- Xeris Pharmaceuticals, Inc.$914
- Novo Nordisk$702
- Lilly USA, LLC$485
- plus $4K from 35 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 33 | $1,826 |
| Amgen(2 entities) | 90 | $1,129 |
| Corcept Therapeutics | 53 | $936 |
| Xeris Pharmaceuticals, Inc. | 57 | $914 |
| Novo Nordisk | 80 | $702 |
| Lilly USA, LLC | 26 | $485 |
| Sanofi-aventis U.S. LLC | 13 | $338 |
| Medtronic | 9 | $279 |
| BETA Bionics, Inc. | 18 | $273 |
| AstraZeneca(2 entities) | 8 | $262 |
| Dexcom, Inc. | 13 | $248 |
| AbbVie | 13 | $239 |
| Boehringer Ingelheim | 12 | $227 |
| Insulet Corporation | 13 | $226 |
| Tandem Diabetes Care, Inc. | 9 | $206 |
| Recordati_rare_diseases_inc. | 7 | $178 |
| Radius Health, Inc. | 9 | $169 |
| Amneal Pharmaceuticals LLC | 8 | $163 |
| Pfizer | 6 | $163 |
| Ascendis Pharma Endocrinology Inc | 7 | $149 |
| Madrigal Pharmaceuticals | 5 | $123 |
| Neurocrine Biosciences, Inc. | 5 | $111 |
| Bayer | 5 | $110 |
| IBSA Pharma Inc. | 5 | $69 |
| Alvogen Inc | 3 | $53 |
| Kyowa Kirin, Inc. | 2 | $47 |
| Verity Pharmaceuticals Inc. | 2 | $46 |
| Antares Pharma, Inc. | 2 | $42 |
| EUSA Pharma (US) LLC | 2 | $41 |
| Ultragenyx Pharmaceutical Inc. | 2 | $40 |
| Mannkind Corporation | 2 | $35 |
| Nevro Corp. | 1 | $31 |
| Amphastar Pharmaceuticals, Inc. | 1 | $21 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| Cequr Corporation | 2 | $20 |
| Halozyme Inc | 1 | $20 |
| GSK | 1 | $18 |
| Evoke Pharma, Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
How this compares
$10,019 in reported general payments places this provider in the 75th percentile of 219 endocrinology, diabetes & metabolism providers in Michigan.
See all endocrinology, diabetes & metabolism providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Flint
- Jamal HammoudFlint$2.6M
- Muhammad BaklehFlint$18K
- Abdallah DlewatiFlint$9K
- Tobias ElseAnn Arbor$3.5M
- Elif OralAnn Arbor$2.9M
- Lowell SchmeltzFarmington Hills$2.3M
- George GrunbergerBloomfield Hills$1.9M
- Richard AuchusAnn Arbor$1.3M
- Ariel BarkanAnn Arbor$553K
- Gary EdelsonFarmington Hills$503K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.